Corbus Pharma Files 2025 DEF 14A
Ticker: CRBP · Form: DEF 14A · Filed: Apr 1, 2025 · CIK: 1595097
Sentiment: neutral
Topics: DEF 14A, executive-compensation, corporate-governance
TL;DR
Corbus Pharma's 2025 DEF 14A is out, detailing exec pay and governance. Check it for investor insights.
AI Summary
Corbus Pharmaceuticals Holdings, Inc. filed a DEF 14A on April 1, 2025, for the fiscal year ending December 31, 2025. The filing details executive compensation and other corporate governance matters. Key information includes the company's principal executive offices located at 500 River Ridge Drive, Norwood, MA 02062, and its fiscal year end of December 31st.
Why It Matters
This filing provides crucial details on executive compensation and corporate governance, which can influence investor decisions and the company's strategic direction.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and corporate governance information, not indicating immediate operational or financial risk.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
Key Players & Entities
- Corbus Pharmaceuticals Holdings, Inc. (company) — Filer
- 500 River Ridge Drive, Norwood, MA 02062 (location) — Principal Executive Offices
- SAV Acquisition Corp (company) — Former Company Name
FAQ
What is the filing date of this DEF 14A?
The filing date is April 1, 2025.
What is the principal business address of Corbus Pharmaceuticals Holdings, Inc.?
The principal business address is 500 River Ridge Drive, Norwood, MA 02062.
When is Corbus Pharmaceuticals Holdings, Inc.'s fiscal year end?
The fiscal year end is December 31st.
What was Corbus Pharmaceuticals Holdings, Inc. formerly known as?
The company was formerly known as SAV Acquisition Corp.
What is the SIC code for Corbus Pharmaceuticals Holdings, Inc.?
The Standard Industrial Classification (SIC) code is 2834, for Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 1, 2025 regarding Corbus Pharmaceuticals Holdings, Inc. (CRBP).